Conversely, treatment of MCL cells and of stimulated B cells with TLR1/2 or TLR5 ligands did not significantly enhance the mRNA levels of cyclin D1 and D3 assessed by qPCR, ruling out the involvement of transcriptional mechanisms (data not shown). The gene discussed is CCND1; the disease is mantle cell lymphoma.